Embedded Files
Resources
Resources for Precision Oncologists
Resources for Precision Oncologists
Curated information. Work in progress
Cancer Common’s observational study
Cancer Common’s observational study
Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients
The aim of this clinical study is to demonstrate that treatment selection tests can identify effective FDA-approved drugs not currently accessible to patients under the NCCN Guidelines.
A key benefit of the study is its site-less nature. Since the treating oncologist is the patient's own oncologist, rather than one preselected for a specific study site, both the patient and their oncologist can participate in the study at any cancer hospital in the US.
Resources for Cancer Patients
Resources for Cancer Patients
Cancer Commons complements the work of your doctors and care team. Our role is to bring clarity, scientific depth, and forward-looking strategies to your decisions.
https://www.cancercommons.org/
Abdera is
Engineering the future of precision radiotherapeutics, combining advanced antibody engineering with radiotherapeutics to attack cancer in bold new ways.
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages.
Personalis: At the forefront of detecting very small traces of cancer recurrence, early.
Google Sites
Report abuse